查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869713

移植診斷市場規模、佔有率和趨勢分析報告：按檢測、產品、應用、移植部位、最終用途、地區和細分市場預測（2025-2033 年）

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test, By Product, By Application, By Transplant Area, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

移植診斷市場摘要

2024年全球移植診斷市場規模估計為63.9億美元，預計2033年將達到121.5億美元。

預計從 2025 年到 2033 年，該市場將以 7.45% 的複合年成長率成長。遺傳疾病的日益普遍、基因檢測技術的進步以及人們對個人化醫療日益成長的認知和需求正在推動市場成長。

例如，2025年10月，UBC酶技術公司啟動了首個通用供體器官移植人體試驗。該公司研發了一種酶，可以將腎臟轉化為通用O型血，用於器官移植，這標誌著在更快、更匹配的器官捐贈方面邁出了重要一步。此外，腎臟在兩天內功能正常，沒有超急性排斥反應的徵兆。超急性排斥反應是一種快速免疫反應，可在數分鐘內破壞不匹配的器官。到第三天，一些血型標記重新出現，引發了輕微的反應。然而，這種損傷遠小於典型的不匹配情況，研究徵兆，人體開始對該器官產生耐受性。

此外，人口老化、慢性病流行以及移植技術的進步正在推動市場成長。例如，世界衛生組織（世衛組織）於2025年10月宣布，至2020年，60歲以上人口數將超過5歲以下兒童數。預計到2050年，全球60歲及以上人口的比例將從2015年的12%幾乎加倍，達到22%。此外，預計到2050年，80%的老年人居住在中低收入國家。與過去相比，人口老化的速度正在顯著加快。隨著心臟衰竭、腎臟病和肝病等慢性病的持續增加，對器官移植這種救命療法的需求也不斷成長。移植手術數量的增加凸顯了精準先進的診斷工具的重要性，以確保捐贈者與受體的匹配，降低器官排斥的風險，並提高移植成功率。

目錄

第1章 移植診斷市場：調查方法與範圍

2. 移植診斷市場：執行摘要

  • 市場概述
  • 檢查
  • 產品概覽
  • 使用情況簡介
  • 移植部位簡介
  • 最終用途簡介
  • 競爭格局概覽

3. 移植診斷市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • 遺傳性疾病盛行率不斷上升
    • 基因檢測技術的進步
    • 人們對個人化醫療的認知和需求日​​益成長
  • 市場限制因素分析
    • 有限的公共衛生檢測
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 移植診斷市場：檢測需求估算與趨勢分析

  • 移植診斷市場：檢測差異分析
  • 分子檢測
    • 基於PCR的分子檢測
    • 即時PCR
    • 基於序列的引子PCR
    • 序列特異性寡核苷酸PCR
    • 其他基於PCR的分子檢測方法
  • 基於定序的分子檢測
    • 桑格定序
    • 次世代定序
    • 其他基於定序的分子檢測方法
  • 非分子檢測
    • 血清學檢測
    • 混合淋巴球培養試驗

第5章 移植診斷市場：產品估算與趨勢分析

  • 移植診斷市場：產品差異分析
  • 試劑和耗材
  • 裝置
  • 軟體和服務

第6章 移植診斷市場：應用預測與趨勢分析

  • 移植診斷市場：應用差異分析
  • 診斷用途
    • 傳染病檢查
    • 組織配對
    • 血液分析
  • 研究用途

第7章 移植診斷市場：移植部位估算與趨勢分析

  • 移植診斷市場：移植部位變異分析
  • 固態區域移植
    • 腎臟移植
    • 肝臟移植
    • 心臟移植
    • 肺移植
    • 胰臟移植
    • 其他器官移植
  • 幹細胞移植
    • 軟組織移植
    • 骨髓移植

第8章 移植診斷市場：終端使用者估算與趨勢分析

  • 移植診斷市場：最終用途差異分析
  • 醫院及移植中心
  • 研究和學術機構
  • 獨立參考實驗室

9. 移植診斷市場：區域業務分析

  • 區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第10章 競爭格局

  • 公司分類
  • 策略規劃
    • 新產品上市
    • 夥伴關係
    • 獲得
    • 合作
    • 資金籌措
  • 主要企業市佔率分析，2024 年
  • 公司熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd
    • Abbott
    • QIAGEN
    • Bruker
    • BD（Becton, Dickinson and Company）
    • Werfen（Immucor, Inc.）
    • Bio-Rad Laboratories, Inc.
    • Omixon Inc.
Product Code: 978-1-68038-970-8

Transplant Diagnostics Market Summary

The global transplant diagnostics market size was estimated at USD 6.39 billion in 2024 and is expected to reach USD 12.15 billion in 2033, growing at a CAGR of 7.45% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, and growing awareness and demand for personalized medicine are boosting the market growth.

For instance, in October 2025, UBC enzyme technology introduced the first human test toward universal donor organs for transplantation. It has developed enzymes that successfully convert a kidney to universal type O for transplant, marking a significant step toward faster, more compatible organ donations. Further, the results show that the kidney functioned normally for two days without evidence of hyperacute rejection. This quick immune reaction can destroy an incompatible organ in minutes. By the third day, some blood-type markers resurfaced, causing a moderate response. Still, the damage was significantly less severe than in a usual mismatch, and researchers noticed signals that the body was starting to tolerate the organ.

Furthermore, the aging population, the prevalence of chronic disease, and advances in transplantation techniques are all driving market growth. For example, in October 2025, the World Health Organization claimed that in 2020, individuals aged 60 and older outnumbered children under five. Between 2015 and 2050, the worldwide population over 60 will almost double, from 12% to 22%. Furthermore, by 2050, 80% of older people will reside in low- and middle-income countries. The pace of population ageing is much faster than in the past. As chronic diseases such as heart failure, kidney disease, and liver disorders continue to rise, the need for organ transplantation as a life-saving treatment is also increasing. This rise in transplant procedures highlights the importance of accurate and advanced diagnostic tools to ensure donor-recipient compatibility, reduce the risk of organ rejection, and improve transplantation success rates.

Global Transplant Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global transplant diagnostics market report based on test, product, application, transplant area, end-use, and region:

  • Test Outlook (Revenue, USD Million, 2021 - 2033)
    • Molecular Assays
  • PCR-based Molecular Assays
  • Real-time PCR
  • Sequence-based Primer-PCR
  • Sequence-specific Oligonucleotide-PCR
  • Other PCR-based Molecular Assays
    • Sequencing-based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing-based Molecular Assays
    • Non-molecular Assays
  • Serological Assays
  • Mixed Lymphocyte Culture Assays
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Reagents & Consumables
    • Instruments
    • Software and Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Diagnostic Application
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
    • Research Application
  • Transplant Area Outlook (Revenue, USD Million, 2021 - 2033)
    • Solid Area Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
    • Stem Cell Transplantation
    • Soft Tissue Transplantation
    • Bone Marrow Transplantation
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals and Transplant Centers
    • Research and Academic Institutes
    • Independent Reference Laboratories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
    • North America
  • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Transplant Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test
      • 1.1.1.2. Product Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. Transplant Area Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Transplant Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test
  • 2.3. Product Snapshot
  • 2.4. Application Snapshot
  • 2.5. Transplant Area Snapshot
  • 2.6. End Use Snapshot
  • 2.7. Competitive Landscape Snapshot

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of genetic disorders
    • 3.4.2. Technological advancements in genetic testing
    • 3.4.3. Growing awareness and demand for personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited implementation of public health screening
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Transplant Diagnostics Market: Test Movement Analysis
  • 4.2. Molecular Assays
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. PCR-based Molecular Assays
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Real-time PCR
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Sequence-based Primer-PCR
      • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.5. Sequence-specific Oligonucleotide-PCR
    • 4.2.6. Other PCR-based Molecular Assays
      • 4.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Sequencing-based Molecular Assays
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Sanger Sequencing
      • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Next Generation Sequencing
      • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Other Sequencing-based Molecular Assays
      • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Non-molecular Assays
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Serological Assays
      • 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Mixed Lymphocyte Culture Assays
      • 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Transplant Diagnostics Market: Product Movement Analysis
  • 5.2. Reagents & Consumables
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Instruments
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Software and Services
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Transplant Diagnostics Market: Application Movement Analysis
  • 6.2. Diagnostic Application
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Infectious Disease Testing
      • 6.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Histocompatibility Testing
      • 6.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Blood Profiling
  • 6.3. Research Application
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

  • 7.1. Transplant Diagnostics Market: Transplant Area Movement Analysis
  • 7.2. Solid Area Transplantation
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. Kidney Transplantation
      • 7.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Liver Transplantation
      • 7.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Heart Transplantation
      • 7.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.5. Lung Transplantation
      • 7.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.6. Pancreas Transplantation
      • 7.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.7. Other Organs Transplantation
      • 7.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Stem Cell Transplantation
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Soft Tissue Transplantation
      • 7.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Bone Marrow Transplantation
      • 7.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Transplant Diagnostics Market: End Use Movement Analysis
  • 8.2. Hospitals and Transplant Centers
    • 8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Research and Academic Institutes
    • 8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Independent Reference Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Business Analysis

  • 9.1. Regional Market Snapshot
  • 9.2. North America
    • 9.2.1. North America Transplant Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.2.2. Key Country Dynamics
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. Reimbursement Scenario
      • 9.2.2.5. Competitive Scenario
    • 9.2.3. Canada
      • 9.2.3.1. Canada Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.3.2. Key Country Dynamics
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Reimbursement Scenario
      • 9.2.3.5. Competitive Scenario
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.2.4.2. Key Country Dynamics
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Reimbursement Scenario
      • 9.2.4.5. Competitive Scenario
  • 9.3. Europe
    • 9.3.1. Europe Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.2.2. Key Country Dynamics
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. Reimbursement Scenario
      • 9.3.2.5. Competitive Scenario
    • 9.3.3. Germany
      • 9.3.3.1. Germany Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.3.2. Key Country Dynamics
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Reimbursement Scenario
      • 9.3.3.5. Competitive Scenario
    • 9.3.4. Spain
      • 9.3.4.1. Spain Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.4.2. Key Country Dynamics
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Reimbursement Scenario
      • 9.3.4.5. Competitive Scenario
    • 9.3.5. France
      • 9.3.5.1. France Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.5.2. Key Country Dynamics
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Reimbursement Scenario
      • 9.3.5.5. Competitive Scenario
    • 9.3.6. Italy
      • 9.3.6.1. Italy Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.6.2. Key Country Dynamics
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Reimbursement Scenario
      • 9.3.6.5. Competitive Scenario
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.7.2. Key Country Dynamics
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Reimbursement Scenario
      • 9.3.7.5. Competitive Scenario
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.8.2. Key Country Dynamics
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Reimbursement Scenario
      • 9.3.8.5. Competitive Scenario
    • 9.3.9. Norway
      • 9.3.9.1. Norway Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.3.9.2. Key Country Dynamics
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Reimbursement Scenario
      • 9.3.9.5. Competitive Scenario
  • 9.4. Asia Pacific
    • 9.4.1. Asia-Pacific Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.2.2. Key Country Dynamics
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Reimbursement Scenario
      • 9.4.2.5. Competitive Scenario
    • 9.4.3. China
      • 9.4.3.1. China Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.3.2. Key Country Dynamics
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Reimbursement Scenario
      • 9.4.3.5. Competitive Scenario
    • 9.4.4. India
      • 9.4.4.1. India Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.4.2. Key Country Dynamics
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. Reimbursement Scenario
      • 9.4.4.5. Competitive Scenario
    • 9.4.5. South Korea
      • 9.4.5.1. South Korea Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.5.2. Key Country Dynamics
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Reimbursement Scenario
      • 9.4.5.5. Competitive Scenario
    • 9.4.6. Thailand
      • 9.4.6.1. Thailand Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.6.2. Key Country Dynamics
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Reimbursement Scenario
      • 9.4.6.5. Competitive Scenario
    • 9.4.7. Australia
      • 9.4.7.1. Australia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.4.7.2. Key Country Dynamics
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Reimbursement Scenario
      • 9.4.7.5. Competitive Scenario
  • 9.5. Latin America
    • 9.5.1. Latin America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.5.2.2. Key Country Dynamics
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Reimbursement Scenario
      • 9.5.2.5. Competitive Scenario
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.5.3.2. Key Country Dynamics
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Reimbursement Scenario
      • 9.5.3.5. Competitive Scenario
  • 9.6. MEA
    • 9.6.1. MEA Transplant Diagnostics Market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.2.2. Key Country Dynamics
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Reimbursement Scenario
      • 9.6.2.5. Competitive Scenario
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.3.2. Key Country Dynamics
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Reimbursement Scenario
      • 9.6.3.5. Competitive Scenario
    • 9.6.4. UAE
      • 9.6.4.1. UAE Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.4.2. Key Country Dynamics
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Reimbursement Scenario
      • 9.6.4.5. Competitive Scenario
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Transplant Diagnostics Market, 2021 - 2033 (USD Million)
      • 9.6.5.2. Key Country Dynamics
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Reimbursement Scenario
      • 9.6.5.5. Competitive Scenario

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
    • 10.2.1. New product launch
    • 10.2.2. Partnerships
    • 10.2.3. Acquisition
    • 10.2.4. Collaboration
    • 10.2.5. Funding
  • 10.3. Key Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Company Profiles
    • 10.5.1. Thermo Fisher Scientific, Inc.
      • 10.5.1.1. Company Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Illumina, Inc.
      • 10.5.2.1. Company Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. F. Hoffmann La-Roche Ltd
      • 10.5.3.1. Company Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Abbott
      • 10.5.4.1. Company Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. QIAGEN
      • 10.5.5.1. Company Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Bruker
      • 10.5.6.1. Company Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. BD (Becton, Dickinson and Company)
      • 10.5.7.1. Company Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Werfen (Immucor, Inc.)
      • 10.5.8.1. Company Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Bio-Rad Laboratories, Inc.
      • 10.5.9.1. Company Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Omixon Inc.
      • 10.5.10.1. Company Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Transplant Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 5 Global Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 6 Global Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 8 Global Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9 North America Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 10 North America Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 11 North America Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 North America Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 North America Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 14 North America Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 16 U.S. Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 17 U.S. Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 U.S. Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 19 U.S. Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Canada Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 21 Canada Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Canada Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Canada Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 24 Canada Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Mexico Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 26 Mexico Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Mexico Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 Mexico Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 29 Mexico Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Europe Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 31 Europe Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 32 Europe Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 Europe Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 34 Europe Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 35 Europe Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 37 UK Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 38 UK Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 UK Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 UK Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Germany Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 42 Germany Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Germany Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Germany Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 45 Germany Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 France Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 47 France Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 France Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 France Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 France Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 Italy Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 52 Italy Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 Italy Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Italy Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 55 Italy Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Spain Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 57 Spain Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 58 Spain Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 Spain Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 60 Spain Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Sweden Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 62 Sweden Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 63 Sweden Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Sweden Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Sweden Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Norway Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 67 Norway Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Norway Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Norway Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 70 Norway Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 Denmark Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 72 Denmark Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 73 Denmark Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Denmark Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Denmark Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 79 Asia-Pacific Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 80 Asia-Pacific Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82 Japan Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 83 Japan Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Japan Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 Japan Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 86 Japan Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 China Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 88 China Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 China Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 China Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 China Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 India Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 93 India Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 94 India Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 India Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 96 India Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 97 Australia Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 98 Australia Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 99 Australia Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 100 Australia Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 101 Australia Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 102 Thailand Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 103 Thailand Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 104 Thailand Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 105 Thailand Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 106 Thailand Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 107 South Korea Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 108 South Korea Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 109 South Korea Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 110 South Korea Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 111 South Korea Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 112 Latin America Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 113 Latin America Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 114 Latin America Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 115 Latin America Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Latin America Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 Latin America Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 118 Brazil Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 119 Brazil Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 120 Brazil Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 121 Brazil Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 122 Brazil Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 123 Argentina Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 124 Argentina Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 125 Argentina Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 126 Argentina Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 127 Argentina Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 128 MEA Transplant Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 129 MEA Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 130 MEA Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 131 MEA Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 132 MEA Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 133 MEA Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 134 South Africa Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 135 South Africa Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 136 South Africa Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 137 South Africa Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 138 South Africa Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 144 UAE Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 145 UAE Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 146 UAE Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 147 UAE Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 148 UAE Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Transplant Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Transplant Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Transplant Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Transplant Diagnostics Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Transplant Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Transplant Diagnostics Market- Key market driver analysis
  • Fig. 7 Transplant Diagnostics Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Transplant Diagnostics Market - Porter's analysis
  • Fig. 10 Transplant Diagnostics Market - PESTEL analysis
  • Fig. 11 Transplant Diagnostics Market Test outlook key takeaways
  • Fig. 12 Transplant Diagnostics Market: Test movement analysis
  • Fig. 13 Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 PCR-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Real-time PCR Market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Sequence-based Primer-PCR Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Sequence-specific Oligonucleotide-PCR Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Other PCR-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Sequencing-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Sanger Sequencing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Next Generation Sequencing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Other Sequencing-based Molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Non-molecular Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Serological Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Mixed Lymphocyte Culture Assays Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Transplant Diagnostics Market Product Outlook Key Takeaways
  • Fig. 27 Transplant Diagnostics Market: Product Movement Analysis
  • Fig. 28 Reagents & Consumables Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Instruments Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Software and Services Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Transplant Diagnostics Market Application Outlook Key Takeaways
  • Fig. 32 Transplant Diagnostics Market Application Movement Analysis
  • Fig. 33 Diagnostic Application Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Infectious Disease Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Histocompatibility Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Blood Profiling Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 37 Research Application Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Transplant Diagnostics Market Transplant Area Outlook Key Takeaways
  • Fig. 39 Transplant Diagnostics Market Transplant Area Movement Analysis
  • Fig. 40 Solid Area Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 41 Kidney Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 42 Liver Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 43 Heart Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 44 Lung Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 45 Pancreas Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 46 Other Organs Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 47 Stem Cell Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 48 Soft Tissue Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 49 Bone Marrow Transplantation Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 50 Transplant Diagnostics Market End Use Outlook Key Takeaways
  • Fig. 51 Transplant Diagnostics Market End Use Movement Analysis
  • Fig. 52 Hospitals and Transplant Centers Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 53 Research and Academic Institutes Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 54 Independent Reference Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Global Transplant Diagnostics Market: Regional movement analysis
  • Fig. 57 North America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Canada Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 62 UK Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 63 Germany Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 64 France Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 65 Spain Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Italy Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 67 Denmark Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 68 Sweden Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 69 Norway Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 71 Japan Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 72 China Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 73 India Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 74 South Korea Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 75 Australia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 78 Brazil Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 79 Argentina Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 83 UAE Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 84 Kuwait Transplant Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 85 Strategy framework